富马酸福莫特罗
富马酸福莫特罗结构式
|
常用名 | 富马酸福莫特罗 | 英文名 | formoterol fumarate dihydrate |
|---|---|---|---|---|
| CAS号 | 183814-30-4 | 分子量 | 840.912 | |
| 密度 | N/A | 沸点 | 603.2ºC at 760 mmHg | |
| 分子式 | C42H56N4O14 | 熔点 | 116-120ºC | |
| MSDS | 中文版 美版 | 闪点 | 318.6ºC |
|
Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro.
PLoS ONE 10 , e0135690, (2015) Pulmonary drug delivery is characterized by short onset times of the effects and an increased therapeutic ratio compared to oral drug delivery. This delivery route can be used for local as well as for systemic absorption applying drugs as single substance or ... |
|
|
Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
Ann. Am. Thorac. Soc. 12 , 798-806, (2015) Guidelines advocate adding long-acting β-agonist (LABA) to inhaled corticosteroid as the preferred step-up therapy to increasing inhaled corticosteroid dose for patients with uncontrolled asthma on inhaled corticosteroid monotherapy. However, less than 5% of ... |
|
|
Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice.
J. Pharmacol. Exp. Ther. 351(3) , 663-73, (2014) Skeletal muscle atrophy remains a clinical problem in numerous pathologic conditions. β2-Adrenergic receptor agonists, such as formoterol, can induce mitochondrial biogenesis (MB) to prevent such atrophy. Additionally, atomoxetine, an FDA-approved norepinephr... |